Atara Biotherapeutics, Inc. (ATRA)
Atara Biotherapeutics Market Cap : 68.16M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 66.22M |
| November 16, 2026 | 65.20M |
| November 13, 2026 | 78.45M |
| November 12, 2026 | 80.79M |
| November 11, 2026 | 83.85M |
| November 10, 2026 | 82.52M |
| November 09, 2026 | 83.34M |
| November 06, 2026 | 80.18M |
| November 05, 2026 | 81.10M |
| November 04, 2026 | 79.04M |
| November 03, 2026 | 77.43M |
| November 02, 2026 | 80.08M |
| October 30, 2026 | 75.64M |
| October 29, 2026 | 80.55M |
| October 28, 2026 | 81.78M |
| October 27, 2026 | 78.38M |
| October 26, 2026 | 78.85M |
| October 23, 2026 | 81.12M |
| October 22, 2026 | 89.05M |
| October 21, 2026 | 88.29M |
| October 20, 2026 | 86.50M |
| October 19, 2026 | 84.61M |
| October 16, 2026 | 86.69M |
| October 15, 2026 | 91.12M |
| October 14, 2026 | 90.28M |
| Date | Value |
|---|---|
| October 13, 2026 | 87.87M |
| October 12, 2026 | 88.58M |
| October 09, 2026 | 89.52M |
| October 08, 2026 | 87.16M |
| October 07, 2026 | 88.48M |
| October 06, 2026 | 92.07M |
| October 05, 2026 | 88.76M |
| October 02, 2026 | 89.52M |
| October 01, 2026 | 79.89M |
| September 30, 2026 | 80.27M |
| September 29, 2026 | 76.02M |
| September 28, 2026 | 79.04M |
| September 25, 2026 | 83.19M |
| September 24, 2026 | 80.64M |
| September 23, 2026 | 80.83M |
| September 22, 2026 | 84.33M |
| September 21, 2026 | 88.58M |
| September 18, 2026 | 91.50M |
| September 17, 2026 | 91.69M |
| September 16, 2026 | 95.47M |
| September 15, 2026 | 89.14M |
| September 14, 2026 | 87.35M |
| September 11, 2026 | 88.58M |
| September 10, 2026 | 93.39M |
| September 09, 2026 | 93.58M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.082B |
| Alnylam Pharmaceuticals, Inc. | 20.01B |
| Anika Therapeutics, Inc. | 182.43M |
| Savara, Inc. | 973.21M |
| Arrowhead Pharmaceuticals, Inc. | 6.092B |
Market Cap Related Metrics
| PS Ratio | 21.83 |
| Price | 6.69 |
| Earnings Yield | -18.33% |